SCHEMBL9547339

SCHEMBL9547339

CC(=O)Nc1cc(COCCCC(=O)[O-])cc(Nc2c3ccccc3nc3ccccc23)c1.CCOC(C(=O)O)c1cc(Nc2c3ccccc3nc3ccccc23)cc(NC(C)C(=O)[O-])c1.[Na+].[Na+]

nearest known ligand 0.42

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 11/20 0.42
TOP2B Q02880 9/20 0.42
KMT2A Q03164 3/20 0.39
KDM4E B2RXH2 3/20 0.39
POLB P06746 3/20 0.39
MAPT P10636 2/20 0.39
RAD52 P43351 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM1A O60341 1/20 0.39
MITF O75030 1/20 0.39
LMNA P02545 1/20 0.39
RECQL P46063 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
GLA P06280 1/20 0.32
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
TERT O14746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9300192 0.86 TOP2A (0.46) TOP2ATOP2BKMT2AKDM4EPOLB
SCHEMBL9547331 0.86 TOP2A (0.44) TOP2ATOP2BKMT2AKDM4EPOLB
SCHEMBL9300201 0.79 TOP2A (0.50) TOP2ATOP2BKMT2AKDM4EPOLB
SCHEMBL9299881 0.77 TOP2A (0.59) TOP2ATOP2BKMT2AKDM4EPOLB
SCHEMBL9300667 0.77 TOP2A (0.53) TOP2ATOP2BKMT2AKDM4EPOLB
SCHEMBL9300188 0.76 TOP2A (0.50) TOP2ATOP2BKMT2AKDM4EPOLB
SCHEMBL9301493 0.76 TOP2A (0.62) TOP2ATOP2BKMT2AKDM4EPOLB
SCHEMBL9300986 0.75 POLB (0.55) TOP2ATOP2BKMT2AKDM4EPOLB
SCHEMBL9300416 0.75 TOP2A (0.49) TOP2ATOP2BKMT2AKDM4EPOLB
SCHEMBL9301435 0.75 TOP2A (0.53) TOP2ATOP2BKMT2AKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993023049-A1 3-(9-ACRIDINYLAMINO)-5-HYDROXYMETHYLANILINE DERIVATIVES AS ANTICANCER AGENTS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-11-25 WO disclosed